Remarkably, αCSF-1 as part of combination therapy not only can enhance the efficacy of chemotherapy by blocking tumor infiltration of myeloid cells but also has the potential to preserve the bone marrow myeloid population and thus alleviate chemotherapy-induced bone marrow suppression. The gene discussed is AACS; the disease is neoplasm.